NeuroCycle Therapeutics Overview
- Year Founded
-
2015
- Status
-
Acquired/Merged
- Latest Deal Type
-
Grant
- Financing Rounds
-
5
NeuroCycle Therapeutics General Information
Description
Opeartor of a pharmaceutical company intended to treat serious inflammatory and neurological disorders. The company focuses on selectively targeting specific receptor subtypes to treat diseases related to central sensitization including chronic itch, chronic pain, and epilepsy syndromes.
Contact Information
Website
www.neurocycletherapeutics.comCorporate Office
- 1 Broadway
- Cambridge, MA 02142
- United States
Corporate Office
- 1 Broadway
- Cambridge, MA 02142
- United States
NeuroCycle Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
NeuroCycle Therapeutics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
NeuroCycle Therapeutics Patents
NeuroCycle Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2020369597-A1 | Treatment of epileptic conditions with gabaa receptor modulators | Inactive | 23-Oct-2019 | ||
| CA-3155618-A1 | Treatment of epileptic conditions with gabaa receptor modulators | Pending | 23-Oct-2019 | ||
| EP-4048266-A1 | Treatment of epileptic conditions with gabaa receptor modulators | Pending | 23-Oct-2019 | ||
| EP-4048266-A4 | Treatment of epileptic conditions with gabaa receptor modulators | Pending | 23-Oct-2019 | ||
| JP-2025157557-A | Treatment of epileptic conditions with gabaa receptor modulators | Pending | 23-Oct-2019 | A61K31/5517 |
NeuroCycle Therapeutics Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
NeuroCycle Therapeutics FAQs
-
When was NeuroCycle Therapeutics founded?
NeuroCycle Therapeutics was founded in 2015.
-
Where is NeuroCycle Therapeutics headquartered?
NeuroCycle Therapeutics is headquartered in Cambridge, MA.
-
What industry is NeuroCycle Therapeutics in?
NeuroCycle Therapeutics’s primary industry is Drug Discovery.
-
Is NeuroCycle Therapeutics a private or public company?
NeuroCycle Therapeutics is a Private company.
-
What is NeuroCycle Therapeutics’s current revenue?
The current revenue for NeuroCycle Therapeutics is .
-
Who are NeuroCycle Therapeutics’s investors?
National Institutes of Arthritis and Musculoskeletal Diseases, National Institutes of Health, National Institutes of Neurological Disorders and Stroke, and Venture Kick have invested in NeuroCycle Therapeutics.
-
When was NeuroCycle Therapeutics acquired?
NeuroCycle Therapeutics was acquired on 15-Feb-2019.
-
Who acquired NeuroCycle Therapeutics?
NeuroCycle Therapeutics was acquired by Engrail Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
